WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCWILLIAM BLAIR INVESTMENT MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2020

SEC EDGAR SourceSEC Filings

Top Holdings339 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

5.6M$1.1B5.3%$137.70+31.92%
6 qtrssince 2018-Q4
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

17.3M$828.3M4.0%$32.36+33.63%
6 qtrssince 2018-Q4
Decreased
0
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

2.1M$552M2.7%$231.03+4.40%
6 qtrssince 2018-Q4
Decreased
0
NTESNTES
ADR

NETEASE INC-ADR

1.2M$385.4M1.9%$45.15+22.63%
6 qtrssince 2018-Q4
Increased
60

BWX TECHNOLOGIES INC

7.8M$378.6M1.8%$36.59+20.73%
6 qtrssince 2018-Q4
Increased
52
TALTAL
ADR

TAL ED GROUP

6.3M$334M1.6%$46.99+10.65%
6 qtrssince 2018-Q4
Increased
79

GRAND CANYON ED INC

4.1M$312.3M1.5%$92.67-18.81%
6 qtrssince 2018-Q4
Increased
65

ENCOMPASS HEALTH CORP

4.6M$291.9M1.4%$45.25+2.43%
6 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

130,797$255M1.2%$76.20+28.87%
6 qtrssince 2018-Q4
Increased
48

TREX INC

3.1M$247.8M1.2%$31.56+34.93%
6 qtrssince 2018-Q4
Decreased
0

CANADIAN NATL RAILWAY CO

3.2M$247.7M1.2%$65.49+4.76%
6 qtrssince 2018-Q4
Decreased
0
HZNPHZNPDelisted

HORIZON THERAPEUTICS PLC

8.3M$246.4M1.2%
4 qtrssince 2019-Q2
Decreased
0

TELEDYNE TECHNOLOGIES INC

818,722$243.4M1.2%$209.50+41.00%
6 qtrssince 2018-Q4
Increased
51

COPART INC

3.4M$230.3M1.1%$14.02+28.11%
6 qtrssince 2018-Q4
Increased
68

BJ'S WHOLESALE CLUB HOLDINGS

9M$229.5M1.1%$25.86-0.99%
4 qtrssince 2019-Q2
Decreased
0

LIVE NATION ENTERTAINMENT IN

4.8M$220.2M1.1%$48.50-6.75%
6 qtrssince 2018-Q4
Increased
57
5M$219.3M1.1%
6 qtrssince 2018-Q4
Decreased
0

MARTIN MARIETTA MATERIALS

1.1M$215.7M1.0%$164.98+4.66%
6 qtrssince 2018-Q4
Increased
53
NICENICE
ADR

NICE LTD - SPON ADR

1.4M$207.7M1.0%$117.15+26.56%
6 qtrssince 2018-Q4
Increased
55

TELEFLEX INCORPORATED

702,708$205.8M1.0%$248.37+12.09%
6 qtrssince 2018-Q4
Increased
49
$20.5B
AUM
339
Positions
Q1 2020
Filing
Rating · 2.5
Quarterly Portfolio Change
+18%Q1'19$23.8B+0%Q2'19$23.8B-2%Q3'19$23.4B+7%Q4'19$25.1B-18%Q1'20$20.5B
Activity profile
$ moved · Q1'20
New12%Increased30%Decreased37%Exited21%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 years
<1Q9%1-4Q16%1-2Y74%2Y+1%

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC manages $20.5B across 339 positions as of Q1 2020. Top holdings: BABA (5.3%), TSM (4.0%), SPY (2.7%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q1 2020 Summary

Active quarter - 41 new positions, 58 exits, 176 increased. Top move: TAL (INCREASED, conviction 79). Portfolio: $20.5B across 339 positions.

Top holdings by portfolio weight

Total AUM$21B
BABA5.30%
TSM4.03%
SPY2.69%
NTES1.88%
BWXT1.84%
TAL1.63%
LOPE1.52%
EHC1.42%
AMZN1.24%
TREX1.21%
Other1.21%

Portfolio allocation by GICS sector

Sectors11
Technology18.40%
Consumer Cyclical14.47%
Unknown14.40%
Healthcare13.93%
Industrials12.58%
Communication Services7.70%
Financial Services7.06%
Consumer Defensive6.56%
Real Estate2.26%
Basic Materials1.62%
Other1.03%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Consumer Cyclical, Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record73
Conviction41
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
DFINDFINDONNELLEY FINL SOLUTIONS INC
Q3 2024 Q2 2026+312,895 shares+$7.5M
7Q
PWPPWPPERELLA WEINBERG PARTNERS
Q4 2024 Q2 2026+3.2M shares+$46.8M
7Q
PRCTPRCTPROCEPT BIOROBOTICS CORP
Q4 2024 Q2 2026+496,982 shares-$1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used